Skip to content
Disclosery

Clearline Capital LP: GMED position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Clearline Capital LP on GMED, newest first. How the timeline and the estimate are built.

Clearline Capital LP held 0 GMED shares at 2025-12-31 per its 13F-HR filed 2026-02-17.

the latest 13F is the newest step

  1. period ended2025-12-31
    13F 0 shares
    Change vs previous 13F -148,472 shares

    13F-HR 0001600136-26-000005 filed by Clearline Capital LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-09-30
    13F 148,472 shares
    Change vs previous 13F +114,917 shares

    0.73% of the 13F portfolio, value $8,502,991.

    13F-HR 0001600136-25-000010 filed by Clearline Capital LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-06-30
    13F 33,555 shares
    Change vs previous 13F +33,555 shares

    0.17% of the 13F portfolio, value $1,980,416.

    13F-HR 0001600136-25-000008 filed by Clearline Capital LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-12-31
    13F 0 shares
    Change vs previous 13F -63,777 shares

    13F-HR 0001600136-25-000005 filed by Clearline Capital LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  5. period ended2024-09-30
    13F 63,777 shares
    Change vs previous 13F not available

    0.4% of the 13F portfolio, value $4,562,607.

    13F-HR 0001600136-24-000009 filed by Clearline Capital LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).